{"disease":{"id":"advanced-gastric-cancer-adenocarcinoma-of-esophagogastric-junction","name":"advanced gastric cancer adenocarcinoma of esophagogastric junction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03045770","title":"mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT03030937","title":"Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":74,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}